June 15th, 2005 RAC Meeting Presentation Outline q Introduction q MGVS Overview

First Page		Document Content
Date: 2013-12-10 12:11:42 Angiogenesis Vascular endothelial growth factor Growth factor Therapeutic angiogenesis Endostatin Vascular endothelial growth factor A Angiology Medicine Biology		June 15th, 2005 RAC Meeting Presentation Outline q Introduction q MGVS Overview Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 2,19 MB Share Document on Facebook

	Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis DocID: 1p0SG - View Document
	PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna DocID: 19ohR - View Document
	Therapeutic Delivery of Nitric Oxide and Carbon Monoxide to Tissue for Accelerated Wound Healing Reference Number OU10001 DocID: 15qmL - View Document
	Contents Preface, G. ARANCIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 DocID: 14lLO - View Document
	Therapeutic effects of human STRO3selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia DocID: 10s0s - View Document